Healthcare Contract Manufacturing Market Research Report - Forecast till 2027

Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/HS/4182-CR | August 2019 | Region: Global | 90 pages

Healthcare Contract Manufacturing Market Scenario:


The Healthcare Contract Manufacturing Market is expected to register 9.86% CAGR and is projected to reach USD 250.9 Billion by 2023. Contract manufacturing refers to a manufacturer who signs a contract with another company to make and provide individual components or products over a mutually agreed period. The healthcare contract manufacturing organization serves other companies in the medical devices and pharmaceutical industries to provide comprehensive services from drug development to drug manufacturing.


Some of the major drivers for the growth of healthcare contract manufacturing market across the globe are patent expiration of major drugs and medical devices, competition and economics of production and trade to favor contract manufacturing organization (CMO), mutual benefits to contract manufacturer and client, and lean manufacturing and agility. On the flip side, supply chain complexity and issues of control of third parties and standardization and interoperability issues are anticipated to hinder the market growth over the forecast period.


Market Dynamics


There is a major patent cliff occurring in the healthcare market worldwide, specifically, in the pharmaceutical industry. The patent cliff will result in cheaper generic versions in the market, which will increase the demand for CMOs. The increased demand is expected to benefit the healthcare contract manufacturing industry. Due to patent expirations, it is assumed that drug sales are anticipated to face a loss of around USD 75 billion between 2016 and 2023. Roughly the drug sales of USD 60 billion is expected to be threatened by generics. The off-patent drugs in 2016 were adalimumab, ledipasvir/sofosbuvir, rituximab, bevacizumab, and trastuzumab. Thus, patent protection expiration of major prescription drugs and the growing demand for generic drugs are likely to boost the growth of CMOs globally.


Global Healthcare Contract Manufacturing Market Size, by Industry, 2016 (%)  Healthcare Contract Manufacturing Market


Source: MRFR Analysis


Segmentation


The healthcare contract manufacturing market has been segmented into type, service type, and industry.


Based on type, the global market has been divided into sterile and non-sterile.


Based on service type, the global market has been segmented into pharmaceutical industry, medical device industry, and biopharmaceutical industry.


Based on industry, the global market has been classified as pharmaceutical industry, medical device industry, and biopharmaceutical industry. The medical devices segment dominated the market in 2016 by holding 43.7% revenue share of the market owing to the rampant growth of the global medical device industry. For instance, according to the Department of Pharmaceuticals, Government of India (GOI), the global medical device market was at USD 228 billion in 2015, which is projected to reach USD 332 billion by 2020.


Regional Analysis


Based on region, the healthcare contract manufacturing market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


In the last couple of decades, contract manufacturers in the Americas have significantly upgraded their factories and manufacturing capabilities with advanced manufacturing units and cost-efficient models. The Americas currently dominates the healthcare contract manufacturing market owing to the presence of major pharmaceutical drug manufacturers, flourishing pharmaceutical industry, and leading medical device companies in the US and Canada.


The contract manufacturing scenario in the market in Europe differs from the Americas in terms of its business model. The major client base of the contract manufacturers in Europe are generic drug companies, whereas, in the Americas, the core client base are branded drug manufacturers. Major factors influencing the growth of the European market include the presence of major manufacturers, boost in the biopharmaceutical sector, government support for research and development, increasing disposable income, and availability of technologically advanced products.


Asia-Pacific is expected to register a comparatively higher CAGR over the forecast period. Countries such as China and India continue to draw a significant amount of outsourcing work from developed countries owing to factors such as large-scale manufacturing capacity, low labor cost, low raw material cost, and low manufacturing cost. Apart from that, some of the major factors influencing the growth of the market include, increasing healthcare expenditure, increasing R&D funding by manufacturers, and moreover multinational medical device manufacturing companies seeking opportunities in the region and expanding their presence in the region. The changing medical device regulatory landscape has been a concern for the healthcare contract manufacturing market in the region. For instance, according to the Organisation for Economic Cooperation and Development (OECD), the average OECD current health spending per capita in 2015 was around twenty times that of the low-income countries and territories in Asia-Pacific (3,800 versus USD PPP 193).


The Middle East & Africa contributes least in the healthcare contract manufacturing market. However, the scenario is changing as the Gulf Cooperation Council (GCC) pharmaceutical and biotechnology companies are undergoing a phase of self-expansion, gearing up to develop a competition for established players in the contract manufacturing market. The increasing development in the Middle Eastern countries for the medical sector, increasing R&D spending, and expansion of multinational companies in the region are also influencing the growth of the market.


Key Players


The prominent players in the healthcare contract manufacturing market are Boehringer Ingelheim, AbbVie, Grifols International, S.A, Lonza AG, Catalant, Aesica Pharmaceuticals, Benchmark Electronics, Evonik Industries, Flex Ltd, Forefront Medical Technologies, Teva Pharmaceutical Industries, Hamilton Company, Sanmina Corporation, Patheon, Mylan, and Vetter Pharma International.


Key strategies followed by the participants of the healthcare contract manufacturing market were innovation, product development, acquisition, and expansion.


Key Updates



  • In April 2019, West Pharmaceutical Services, Inc. (US), a global leader in innovative solutions for injectable drug administration, has expanded its presence in Asia-Pacific with a new sales office in South Korea.



  • In March 2019, Nemera and Novo Nordisk A/S collaborated to build a new manufacturing site in France to manufacture injectable devices. This collaboration supported market growth in the country.



  • In August 2018, Catalent, Inc. acquired Juniper Pharmaceuticals, Inc., a UK-based company, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing. This acquisition has expanded and strengthened Catalent’s offerings in formulation development, bioavailability solutions and clinical-scale oral dose manufacturing, and complemented its integrated worldwide clinical and commercial supply network.


Market Segmentation


Healthcare Contract Manufacturing Market, by Type



  • Sterile

  • Non-Sterile


Healthcare Contract Manufacturing Market, by Service Type



  • Pharmaceutical Contract Manufacturing

  • Medical Device Contract Manufacturing


Healthcare Contract Manufacturing Market, by Industry



  • Pharmaceutical Industry

  • Medical Device Industry

  • Biopharmaceutical Industry


Healthcare Contract Manufacturing Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • UAE

    • Saudi Arabia

    • Oman

    • Kuwait

    • Qatar

    • Rest of Middle East & Africa




Available Additional Customizations



  • Additional Companies

    • Jabil Inc.

    • Nipro Corporation

    • Flex, Ltd.

    • West Pharmaceutical Services, Inc.

    • Phillips-Medisize Corporation



  • Mega Trends in the Market

  • Pricing Analysis


Intended Audience



  • Pharmaceutical and biotechnology companies

  • Pharmaceutical and biotechnology manufacturers and distributors

  • Medical device manufacturers and distributors

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 250.9 Billion
  • 2027: Significant Value
  •   CAGR   9.86% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Industry
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Boehringer Ingelheim, AbbVie, Grifols International, S.A, Lonza AG, Catalant, Aesica Pharmaceuticals, Benchmark Electronics, Evonik Industries, Flex Ltd, Forefront Medical Technologies, Teva Pharmaceutical Industries, Hamilton Company, Sanmina Corporation, Patheon, Mylan, and Vetter Pharma International.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Patent expiration of major drugs and medical devices
  • Competition and economics of production and trade to favor contract manufacturing organization (CMO)
  • Mutual benefits to contract manufacturer and client
  • Lean manufacturing and agility


  • Frequently Asked Questions (FAQ) :


    Healthcare contract manufacturing market projected to grow at approximately 9.86% CAGR during the assessment period (2017-2023).

    The valuation of the healthcare contract manufacturing market is estimated to increase to USD 250.9 BN by the end of 2023.

    Major cliffing in the healthcare and pharmaceutical industry worldwide and government support, are major tailwinds pushing the growth of the healthcare contract manufacturing market.

    North America holds the largest share in thehealthcare contract manufacturing market, followed by Europe and the Asia Pacific, respectively.

    AbbVie, Boehringer Ingelheim, Vetter Pharma International, Grifols International, S.A, Mylan, Catalant, Lonza AG, Patheon, Sanmina Corporation, Aesica Pharmaceuticals, Hamilton Company, Evonik Industries, Benchmark Electronics, Flex Ltd, Teva Pharmaceutical Industries, and Forefront Medical Technologies, are some of the top players operating in the healthcare contract manufacturing market.

    1 Report Prologue

    2 Market Introduction

    2.1 Definition 19

    2.2 Scope of the Study 19

    2.3 List of Assumptions 19

    2.4 Market Structure 20

    3 Research Methodology

    3.1 Research Process 22

    3.2 Primary Research 23

    3.3 Secondary Research 24

    3.4 Market Size Estimation 25

    3.5 Forecast Model 25

    4 Market Dynamics

    4.1 Introduction 27

    4.2 Drivers 28

    4.2.1 Patent Protection Expiration of Major Drugs and Medical Devices Will Boost the Market Growth 28

    4.2.2 Competition and Economics of Production and Trade to Favor CMO 28

    4.2.3 Mutual Benefits to Both Contract Manufacturer and Client are Likely to Have a Positive Impact on Healthcare Contract Manufacturing 28

    4.2.4 Lean Manufacturing and Agility 29

    4.3 Restraints 30

    4.3.1 Supply Chain Complexity and Issues of Control of 3rd Parties May Hamper the Market 30

    4.3.2 Standardization and Interoperability Issues 30

    4.3.3 Growing Cost of Noncompliance and Counterfeited Medicines May Hamper the Market Growth 30

    4.4 Opportunities 31

    4.4.1 Research & Development 31

    4.4.2 Personalization & Customization 31

    4.5 Challenges 32

    4.5.1 Loss of Research and Innovation Ability 32

    4.5.2 Growth in Exposure to Natural and Human-Made Threats 32

    5 Market Factor Analysis

    5.1 Value/Supply Chain Analysis 34

    5.1.1 Raw Material 34

    5.1.2 Supplier 34

    5.1.3 Manufacturer 35

    5.1.4 Distributor 36

    5.1.5 Customer 36

    5.1.6 Consumer 36

    5.2 Porter’s Five Force Analysis 37

    5.2.1 Threat from a New Entrant 38

    5.2.2 Bargaining Power of Buyer 38

    5.2.3 Bargaining Power of Supplier 39

    5.2.4 Threat from Substitute 39

    5.2.5 Rivalry 39

    5.3 Investment Opportunity Analysis 40

    5.3.1 Market Size (Current & Future), Growth Rate & Profitability 40

    5.3.2 Investment Risks 40

    5.3.3 Market outlook 40

    6 Global Healthcare Contract Manufacturing Market, by Type

    6.1 Overview 42

    6.1.1 Sterile 43

    6.1.2 Non-Sterile 43

    7 Global Healthcare Contract Manufacturing Market, by Service Type

    7.1 Overview 45

    7.1.1 Pharmaceutical Contract Manufacturing 46

    7.1.2 Medical Device Contract Manufacturing 47

    8 Global Healthcare Contract Manufacturing Market, by Industry

    8.1 Overview 50

    8.1.1 Pharmaceutical Industry 51

    8.1.2 Medical Device Industry 52

    8.1.3 Biopharmaceutical Industry 52

    9 Global Healthcare Contract Manufacturing Market, by Region

    9.1 Introduction 54

    9.2 Americas 56

    9.2.1 North America 59

    9.2.1.1 US. 62

    9.2.1.2 Canada 64

    9.2.2 South America 67

    9.3 Europe 70

    9.3.1 Western Europe 73

    9.3.1.1 Germany 76

    9.3.1.2 France 78

    9.3.1.3 US 81

    9.3.1.4 Italy 83

    9.3.1.5 Spain 85

    9.3.1.6 Rest of Western Europe 88

    9.3.2 Eastern Europe 90

    9.4 Asia-Pacific 93

    9.4.1 Japan 96

    9.4.2 China 99

    9.4.3 India 101

    9.4.4 Australia 104

    9.4.5 South Korea 106

    9.4.6 Rest of Asia-Pacific 108

    9.5 Middle East & Africa 111

    9.5.1 United Arab Emirates 114

    9.5.2 Saudi Arabia 117

    9.5.3 Oman 119

    9.5.4 Kuwait 122

    9.5.5 Qatar 124

    9.5.6 Rest of Middle East & Africa 126

    10 Competitive Landscape

    10.1 Introduction 130

    10.1.1 Company Share Analysis 130

    11 Company Profiles

    11.1 Catalant 133

    11.1.1 Company Overview 133

    11.1.2 Financial Overview 133

    11.1.3 Products/Services Offered 134

    11.1.4 Key Developments 134

    11.1.5 SWOT Analysis 134

    11.1.6 Key Strategies 134

    11.2 Boehringer Ingelheim 135

    11.2.1 Company Overview 135

    11.2.2 Financial Overview 135

    11.2.3 Products/Services Offered 136

    11.2.4 Key Developments 136

    11.2.5 SWOT Analysis 137

    11.2.6 Key Strategies 137

    11.3 Lonza AG 138

    11.3.1 Company Overview 138

    11.3.2 Financial Overview 138

    11.3.3 Products/Services Offered 139

    11.3.4 Key Developments 139

    11.3.5 SWOT Analysis 139

    11.3.6 Key Strategies 139

    11.4 Grifols International, S.A 140

    11.4.1 Company Overview 140

    11.4.2 Financial Overview 140

    11.4.3 Products/Services Offered 141

    11.4.4 Key Developments 141

    11.4.5 SWOT Analysis 141

    11.4.6 Key Strategies 141

    11.5 AbbVie Inc 142

    11.5.1 Company Overview 142

    11.5.2 Financial Overview 142

    11.5.3 Products/Services Offered 143

    11.5.4 Key Developments 143

    11.5.5 SWOT Analysis 143

    11.5.6 Key Strategies 143

    11.6 Patheon Inc 144

    11.6.1 Company Overview 144

    11.6.2 Financial Overview 144

    11.6.3 Products/Services Offered 145

    11.6.4 Key Developments 145

    11.6.5 SWOT Analysis 145

    11.6.6 Key Strategies 145

    11.7 Vetter Pharma 146

    11.7.1 Company Overview 146

    11.7.2 Financial Overview 146

    11.7.3 Products/Services Offered 146

    11.7.4 Key Developments 146

    11.7.5 SWOT Analysis 147

    11.7.6 Key Strategies 147

    11.8 Pharmaceutical Product Development 148

    11.8.1 Company Overview 148

    11.8.2 Financial Overview 148

    11.8.3 Products/Services Offered 148

    11.8.4 Key Developments 149

    11.8.5 SWOT Analysis 149

    11.8.6 Key Strategies 149

    11.9 Teva Pharmaceutical Industries Limited 150

    11.9.1 Company Overview 150

    11.9.2 Financial Overview 150

    11.9.3 Products/Services Offered 151

    11.9.4 Key Developments 151

    11.9.5 SWOT Analysis 151

    11.9.6 Key Strategies 151

    11.10 Aesica Pharmaceuticals Ltd 152

    11.10.1 Company Overview 152

    11.10.2 Financial Overview 152

    11.10.3 Products/Services Offered 152

    11.10.4 Key Developments 152

    11.10.5 SWOT Analysis 153

    11.10.6 Key Strategies 153

    11.11 Pfizer Inc. 154

    11.11.1 Company Overview 154

    11.11.2 Financial Overview 154

    11.11.3 Products/Services Offered 155

    11.11.4 Key Developments 155

    11.11.5 SWOT Analysis 155

    11.11.6 Key Strategies 155

    11.12 Baxter Biopharma Solutions 156

    11.12.1 Company Overview 156

    11.12.2 Financial Overview 156

    11.12.3 Products/Services Offered 157

    11.12.4 Key Developments 157

    11.12.5 SWOT Analysis 158

    11.12.6 Key Strategies 158

    11.13 Jubilant Life Sciences Limited 159

    11.13.1 Company Overview 159

    11.13.2 Financial Overview 159

    11.13.3 Products/Services Offered 160

    11.13.4 Key Developments 160

    11.13.5 SWOT Analysis 160

    11.13.6 Key Strategies 160

    11.14 Nipro Corporation 161

    11.14.1 Company Overview 161

    11.14.2 Financial Overview 161

    11.14.3 Products/Services Offered 162

    11.14.4 Key Developments 162

    11.14.5 SWOT Analysis 162

    11.14.6 Key Strategies 162

    11.15 NextPharma Technologies 163

    11.15.1 Company Overview 163

    11.15.2 Financial Overview 163

    11.15.3 Products/Services Offered 164

    11.15.4 Key Developments 164

    11.15.5 SWOT Analysis 164

    11.15.6 Key Strategies 164

    12 Conclusion

    12.1 Key Findings 166

    12.1.1 Key Companies to Watch 166

    12.1.2 Prediction of the Healthcare Contract Manufacturing Industry 166

    13 Appendix

    13.1 Discussion Blue Print 168

    14 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 19

    TABLE 2 PRIMARY INTERVIEWS 22

    TABLE 3 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 43

    TABLE 4 GLOBAL STERILE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 43

    TABLE 5 GLOBAL NON-STERILE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 43

    TABLE 6 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 46

    TABLE 7 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 46

    TABLE 8 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 46

    TABLE 9 GLOBAL FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 47

    TABLE 10 GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 47

    TABLE 11 GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 47

    TABLE 12 GLOBAL DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 48

    TABLE 13 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 51

    TABLE 14 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR PHARMACEUTICAL INDUSTRY BY REGION, 2020-2027 (USD BILLION) 51

    TABLE 15 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR MEDICAL DEVICE INDUSTRY BY REGION, 2020-2027 (USD BILLION) 52

    TABLE 16 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR BIOPHARMACEUTICAL INDUSTRY BY REGION, 2020-2027 (USD BILLION) 52

    TABLE 17 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 55

    TABLE 18 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 56

    TABLE 19 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 57

    TABLE 20 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 57

    TABLE 21 AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 57

    TABLE 22 AMERICAS FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 58

    TABLE 23 AMERICAS MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 58

    TABLE 24 AMERICAS DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 58

    TABLE 25 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 59

    TABLE 26 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 59

    TABLE 27 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 60

    TABLE 28 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 60

    TABLE 29 NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 60

    TABLE 30 NORTH AMERICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 61

    TABLE 31 NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 61

    TABLE 32 NORTH AMERICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 61

    TABLE 33 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 62

    TABLE 34 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 62

    TABLE 35 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 62

    TABLE 36 US PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 63

    TABLE 37 US FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 63

    TABLE 38 US MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 63

    TABLE 39 US DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 64

    TABLE 40 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 64

    TABLE 41 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 64

    TABLE 42 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 65

    TABLE 43 CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 65

    TABLE 44 CANADA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 65

    TABLE 45 CANADA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 66

    TABLE 46 CANADA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 66

    TABLE 47 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 66

    TABLE 48 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 67

    TABLE 49 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 67

    TABLE 50 SOUTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 67

    TABLE 51 SOUTH AMERICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 68

    TABLE 52 SOUTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 68

    TABLE 53 SOUTH AMERICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 68

    TABLE 54 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 69

    TABLE 55 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 70

    TABLE 56 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 71

    TABLE 57 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 71

    TABLE 58 EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 71

    TABLE 59 EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 72

    TABLE 60 EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 72

    TABLE 61 EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 72

    TABLE 62 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 73

    TABLE 63 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 73

    TABLE 64 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 74

    TABLE 65 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 74

    TABLE 66 WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 74

    TABLE 67 WESTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 75

    TABLE 68 WESTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 75

    TABLE 69 WESTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 75

    TABLE 70 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 76

    TABLE 71 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 76

    TABLE 72 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 76

    TABLE 73 GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 77

    TABLE 74 GERMANY FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 77

    TABLE 75 GERMANY MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 77

    TABLE 76 GERMANY DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 78

    TABLE 77 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 78

    TABLE 78 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 78

    TABLE 79 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 79

    TABLE 80 FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 79

    TABLE 81 FRANCE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 79

    TABLE 82 FRANCE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 80

    TABLE 83 FRANCE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 80

    TABLE 84 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 80

    TABLE 85 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 81

    TABLE 86 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 81

    TABLE 87 UK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 81

    TABLE 88 UK FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 82

    TABLE 89 UK MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 82

    TABLE 90 UK DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 82

    TABLE 91 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 83

    TABLE 92 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 83

    TABLE 93 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 83

    TABLE 94 ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 84

    TABLE 95 ITALY FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 84

    TABLE 96 ITALY MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 84

    TABLE 97 ITALY DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 85

    TABLE 98 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 85

    TABLE 99 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 85

    TABLE 100 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 86

    TABLE 101 SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 86

    TABLE 102 SPAIN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 86

    TABLE 103 SPAIN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 87

    TABLE 104 SPAIN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 87

    TABLE 105 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 87

    TABLE 106 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 88

    TABLE 107 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 88

    TABLE 108 REST OF WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 88

    TABLE 109 REST OF WESTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 89

    TABLE 110 REST OF WESTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 89

    TABLE 111 REST OF WESTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 89

    TABLE 112 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 90

    TABLE 113 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 90

    TABLE 114 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 90

    TABLE 115 EASTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 91

    TABLE 116 EASTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 91

    TABLE 117 EASTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 91

    TABLE 118 EASTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 92

    TABLE 119 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 92

    TABLE 120 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 93

    TABLE 121 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 94

    TABLE 122 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 94

    TABLE 123 ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 94

    TABLE 124 ASIA-PACIFIC FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 95

    TABLE 125 ASIA-PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 95

    TABLE 126 ASIA-PACIFIC DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 95

    TABLE 127 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 96

    TABLE 128 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 96

    TABLE 129 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 96

    TABLE 130 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 97

    TABLE 131 JAPAN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 97

    TABLE 132 JAPAN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 97

    TABLE 133 JAPAN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 98

    TABLE 134 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 98

    TABLE 135 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 99

    TABLE 136 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 99

    TABLE 137 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 99

    TABLE 138 CHINA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 100

    TABLE 139 CHINA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 100

    TABLE 140 CHINA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 100

    TABLE 141 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 101

    TABLE 142 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 101

    TABLE 143 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 101

    TABLE 144 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 102

    TABLE 145 INDIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 102

    TABLE 146 INDIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 102

    TABLE 147 INDIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 103

    TABLE 148 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 103

    TABLE 149 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 104

    TABLE 150 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 104

    TABLE 151 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 104

    TABLE 152 AUSTRALIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 105

    TABLE 153 AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 105

    TABLE 154 AUSTRALIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 105

    TABLE 155 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 106

    TABLE 156 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 106

    TABLE 157 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 106

    TABLE 158 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 107

    TABLE 159 SOUTH KOREA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 107

    TABLE 160 SOUTH KOREA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 107

    TABLE 161 SOUTH KOREA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 108

    TABLE 162 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 108

    TABLE 163 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 108

    TABLE 164 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 109

    TABLE 165 REST OF ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 109

    TABLE 166 REST OF ASIA-PACIFIC FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 109

    TABLE 167 REST OF ASIA-PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 110

    TABLE 168 REST OF ASIA-PACIFIC DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 110

    TABLE 169 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 110

    TABLE 170 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 111

    TABLE 171 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 112

    TABLE 172 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 112

    TABLE 173 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 112

    TABLE 174 MIDDLE EAST & AFRICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 113

    TABLE 175 MIDDLE EAST & AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 113

    TABLE 176 MIDDLE EAST & AFRICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 113

    TABLE 177 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 114

    TABLE 178 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 114

    TABLE 179 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 114

    TABLE 180 UAE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 115

    TABLE 181 UAE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 115

    TABLE 182 UAE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 115

    TABLE 183 UAE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 116

    TABLE 184 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 116

    TABLE 185 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 117

    TABLE 186 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 117

    TABLE 187 SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 117

    TABLE 188 SAUDI ARABIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 118

    TABLE 189 SAUDI ARABIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 118

    TABLE 190 SAUDI ARABIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 118

    TABLE 191 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 119

    TABLE 192 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 119

    TABLE 193 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 119

    TABLE 194 OMAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 120

    TABLE 195 OMAN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 120

    TABLE 196 OMAN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 120

    TABLE 197 OMAN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 121

    TABLE 198 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 121

    TABLE 199 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 122

    TABLE 200 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 122

    TABLE 201 KUWAIT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 122

    TABLE 202 KUWAIT FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 123

    TABLE 203 KUWAIT MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 123

    TABLE 204 KUWAIT DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 123

    TABLE 205 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 124

    TABLE 206 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 124

    TABLE 207 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 124

    TABLE 208 QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 125

    TABLE 209 QATAR FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 125

    TABLE 210 QATAR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 125

    TABLE 211 QATAR DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 126

    TABLE 212 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 126

    TABLE 213 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 126

    TABLE 214 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 127

    TABLE 215 REST OF MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 127

    TABLE 216 REST OF MIDDLE EAST & AFRICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 127

    TABLE 217 REST OF MIDDLE EAST & AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 128

    TABLE 218 REST OF MIDDLE EAST & AFRICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 128

    TABLE 219 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 128

    15 List of Figures

    FIGURE 1 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET: MARKET STRUCTURE 20

    FIGURE 2 RESEARCH PROCESS OF MRFR 22

    FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 25

    FIGURE 4 MARKET DYNAMIC ANALYSIS OF THE GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET 27

    FIGURE 5 DRIVERS IMPACT ANALYSIS: HEALTHCARE CONTRACT MANUFACTURING MARKET 29

    FIGURE 6 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE CONTRACT MANUFACTURING MARKET 31

    FIGURE 7 VALUE CHAIN: HEALTHCARE CONTRACT MANUFACTURING MARKET 34

    FIGURE 8 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET 37

    FIGURE 9 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020 & 2027 (USD BILLION) 42

    FIGURE 10 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2020 (%) 42

    FIGURE 11 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020 & 2027 (USD BILLION) 45

    FIGURE 12 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY SERVICE TYPE, 2020 (%) 45

    FIGURE 13 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020 & 2027 (USD BILLION) 50

    FIGURE 14 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY INDUSTRY, 2020 (%) 51

    FIGURE 15 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 & 2027 (USD BILLION) 54

    FIGURE 16 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY REGION, 2020 (%) 55

    FIGURE 17 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 (%) 56

    FIGURE 18 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 59

    FIGURE 19 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 (%) 70

    FIGURE 20 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 73

    FIGURE 21 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 93

    FIGURE 22 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 111

    FIGURE 23 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 130